XML 95 R73.htm IDEA: XBRL DOCUMENT
v3.25.2

SHARE CAPITAL (Disclosure of outstanding options to acquire common shares) (Details) | 12 Months Ended |
--- | --- | ---
Mar. 31, 2025 Share $ / shares | Mar. 31, 2024 Share $ / shares | Mar. 31, 2023 Share $ / shares
Options Outstanding |  |  |
Number of options outstanding | Share | 6,123,334 | 7,098,334 |
Weighted Average Remaining Contractual Life (years) | 2 years 3 months 29 days | 1 year 10 months 2 days |
Weighted average exercise price | $ 2.32 | $ 2.37 |
Options Exercisable |  |  |
Number of share options exercisable | Share | 4,793,750 | 6,390,001 |
Weighted average exercise price | $ 2.54 | $ 2.41 |
Triera Biosciences Ltd [Member] |  |  |
Options Outstanding |  |  |
Number of options outstanding | Share | 190,000 | 195,000 | 0
Weighted average exercise price | $ 1 | $ 1 | $ 0
$0.40 - $1.00 [Member] |  |  |
Options Outstanding |  |  |
Number of options outstanding | Share | 633,334 | 2,333,334 |
Weighted Average Remaining Contractual Life (years) | 3 months 10 days | 9 months 14 days |
Weighted average exercise price | $ 0.55 | $ 0.48 |
Options Exercisable |  |  |
Number of share options exercisable | Share | 633,334 | 2,333,334 |
Weighted average exercise price | $ 0.55 | $ 0.48 |
$0.40 - $1.00 [Member] | Minimum [Member] |  |  |
Options Outstanding |  |  |
Weighted average exercise price | 0.4 | 0.4 |
$0.40 - $1.00 [Member] | Maximum [Member] |  |  |
Options Outstanding |  |  |
Weighted average exercise price | $ 1 | $ 1 |
$1.01 - $4.00 [Member] |  |  |
Options Outstanding |  |  |
Number of options outstanding | Share | 4,465,000 | 3,025,000 |
Weighted Average Remaining Contractual Life (years) | 2 years 9 months | 2 years 6 months 7 days |
Weighted average exercise price | $ 2.12 | $ 2.63 |
Options Exercisable |  |  |
Number of share options exercisable | Share | 3,135,416 | 2,316,667 |
Weighted average exercise price | $ 2.37 | $ 2.81 |
$1.01 - $4.00 [Member] | Minimum [Member] |  |  |
Options Outstanding |  |  |
Weighted average exercise price | 1.01 | 1.01 |
$1.01 - $4.00 [Member] | Maximum [Member] |  |  |
Options Outstanding |  |  |
Weighted average exercise price | $ 4 | $ 4 |
$4.01 - $5.67[Member] |  |  |
Options Outstanding |  |  |
Number of options outstanding | Share | 1,025,000 | 1,740,000 |
Weighted Average Remaining Contractual Life (years) | 1 year 9 months 14 days | 2 years 14 days |
Weighted average exercise price | $ 4.27 | $ 4.46 |
Options Exercisable |  |  |
Number of share options exercisable | Share | 1,025,000 | 1,740,000 |
Weighted average exercise price | $ 4.27 | $ 4.46 |
$4.01 - $5.67[Member] | Minimum [Member] |  |  |
Options Outstanding |  |  |
Weighted average exercise price | 4.01 | 4.01 |
$4.01 - $5.67[Member] | Maximum [Member] |  |  |
Options Outstanding |  |  |
Weighted average exercise price | $ 5.67 | $ 5.67 |
$0.00 - $1.00 [Member] | Triera Biosciences Ltd [Member] |  |  |
Options Outstanding |  |  |
Number of options outstanding | Share | 200,000 | 195,000 |
Weighted Average Remaining Contractual Life (years) | 3 years 2 months 19 days | 4 years 3 months |
Weighted average exercise price | $ 1 | $ 1 |
Options Exercisable |  |  |
Number of share options exercisable | Share | 196,666 | 65,000 |
Weighted average exercise price | $ 1 | $ 1 |
$0.00 - $1.00 [Member] | Minimum [Member] | Triera Biosciences Ltd [Member] |  |  |
Options Outstanding |  |  |
Weighted average exercise price | 0 | 0 |
$0.00 - $1.00 [Member] | Maximum [Member] | Triera Biosciences Ltd [Member] |  |  |
Options Outstanding |  |  |
Weighted average exercise price | $ 1 | $ 1 |

X
- Definition The number of share options outstanding in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_i&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vi&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOutstandingShareOptions
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of share options exercisable in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause vii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vii&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause vii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vii&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_i&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vi&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Options Exercisable [Abstract] + References No definition available. + Details
Name: | ztek_OptionsExercisableAbstract
Namespace Prefix: | ztek_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number Of Options Outstanding [Abstract] + References No definition available. + Details
Name: | ztek_OptionsOutstandingAbstract
Namespace Prefix: | ztek_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ztek_TrieraBiosciencesLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ztek_RangeOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ztek_RangeTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ztek_RangeThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ztek_RangeOfExercisePricesOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |